Efficacy and Safety of Aflapin, a Novel Boswellia serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study
Abstract
In a 30-day randomized, double-blind, placebo-controlled study, the Boswellia serrata extract Aflapin significantly reduced pain and improved function in knee osteoarthritis and lowered inflammatory and cartilage biomarkers (MMP-3, TNF-alpha, hs-CRP).
Referenced for these plants
How to cite
Karlapudi, V., Sunkara, K.B., Konda, P.R., Sarma, K.V. and Rokkam, M.P (2022) 'Efficacy and Safety of Aflapin, a Novel Boswellia serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study', Journal of the American Nutrition Association, 42(2), pp. 159-168. doi:10.1080/07315724.2021.2014370
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.